EQRx, Inc. Warrant (EQRXW)

EQRXW was delisted on the 8th of November, 2023.

• Market cap: $22.1M
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: EQRx Inc is a biotechnology company. the company has more than 10 programs in its pipeline, including clinical, preclinical and drug engineering targets for the treatment of oncology and immune-inflammatory conditions. The program includes Aumolertinib, Lerociclib, Sugemalimab, Nofazinlimab, and others.

Employees: 363